AQR Capital Management - IRADIMED CORP ownership

IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 102 filers reported holding IRADIMED CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of IRADIMED CORP
ValueSharesWeighting
Q3 2023$433,184
-7.2%
9,763
-0.2%
0.00%0.0%
Q2 2023$466,849
-7.4%
9,779
-41.6%
0.00%0.0%
Q3 2022$504,000
-43.0%
16,755
-35.6%
0.00%
-50.0%
Q2 2022$884,000
+305.5%
26,034
+436.5%
0.00%
Q1 2022$218,000
-8.0%
4,853
-53.2%
0.00%
Q4 2020$237,000
-64.0%
10,377
-66.3%
0.00%
-100.0%
Q3 2020$659,000
-28.1%
30,836
-22.0%
0.00%0.0%
Q2 2020$917,000
-16.1%
39,527
-22.8%
0.00%
-50.0%
Q1 2020$1,093,000
-18.1%
51,202
-10.3%
0.00%0.0%
Q4 2019$1,335,000
-16.2%
57,097
-24.6%
0.00%0.0%
Q3 2019$1,593,000
+225.1%
75,764
+216.1%
0.00%
+100.0%
Q2 2019$490,000
+10.6%
23,971
+52.1%
0.00%
Q1 2019$443,000
+99.5%
15,764
+73.4%
0.00%
Q4 2018$222,000
-58.0%
9,091
-64.3%
0.00%
-100.0%
Q2 2018$529,000
-5.7%
25,499
-35.9%
0.00%0.0%
Q1 2018$561,000
-40.6%
39,808
-36.1%
0.00%0.0%
Q4 2017$944,000
+5.5%
62,294
-33.2%
0.00%0.0%
Q3 2017$895,000
-29.0%
93,275
-36.4%
0.00%
-50.0%
Q2 2017$1,260,000
+2.9%
146,581
+6.5%
0.00%0.0%
Q1 2017$1,225,000
+1.0%
137,663
+25.9%
0.00%0.0%
Q4 2016$1,213,000
+29.0%
109,318
+97.7%
0.00%
+100.0%
Q3 2016$940,000
-10.5%
55,307
+14.6%
0.00%
-50.0%
Q2 2016$1,050,000
+61.0%
48,264
+41.7%
0.00%
+100.0%
Q1 2016$652,000
+64.6%
34,050
+141.0%
0.00%0.0%
Q4 2015$396,00014,1270.00%
Other shareholders
IRADIMED CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 140,752$3,290,0003.17%
RK Capital 222,914$5,212,0001.95%
Nine Ten Capital Management LLC 130,272$3,046,0000.76%
Parkman Healthcare Partners LLC 93,500$2,186,0000.63%
Ranger Investment Management 244,963$5,727,0000.38%
CADENCE CAPITAL MANAGEMENT LLC 107,043$2,503,0000.27%
ALGERT GLOBAL LLC 29,652$693,0000.21%
Mondrian Investment Partners LTD 163,939$3,833,0000.10%
NAVELLIER & ASSOCIATES INC 20,800$486,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 56,811$1,328,0000.04%
View complete list of IRADIMED CORP shareholders